As protein accretion is a prerequisite for growth, studying the mechanisms by which nutrients and hormones promote protein gain is of the utmost relevance to paediatric endocrinology. Tracers are ideally suited for the assessment of protein and amino acid kinetics in vivo, as they provide an estimate of synthesis and turnover. Current tracer approaches in children and adolescents utilize stable isotopes, ‘heavier’ forms of elements that have one or several extra neutrons in the nucleus. Such isotopes are already present at low, but significant, levels in all tissues and foodstuffs, are not radioactive and are devoid of any known side-effects when present in small amounts. L-[1-13C] labelled leucine, given as a 4- to 6-h intravenous infusion, has become the method of choice to assess whole-body protein kinetics. After infusion, any 13C-leucinethat is oxidized appears in the breath as 13CO2, whereas the remainder is incorporated into body proteins through protein synthesis. The isotope enrichments are determined by isotope ratio mass spectrometry and gas chromatography mass spectrometry, and absolute rates of whole-body protein synthesis, oxidation, and breakdown can be extrapolated. This approach has been used extensively to investigate the regulation of protein kinetics by nutrients and by hormones. Attempts have also been made to measure amino acid/protein metabolism in selected body compartments, and to measure the kinetics of specific tissue proteins, for example, muscle, gut, or plasma proteins.

1.
Micheli JL, Schutz Y, Jéquier E: Protein metabolism of the newborn; in Polin RA, Fox WW (eds): Fetal and Neonatal Physiology vol 1, chapter 44. Philadelphia PA, Saunders, 1992, pp 462–472.
2.
Matthews DE, Motil KJ, Rohrbaugh DK, Burke JF, Young VR, Bier DM: Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1–3C]leucine. Am J Physiol 1980;238:E473–E479.
3.
Wolfe RR: Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. New York, Wiley-Liss, 1992.
4.
Darmaun D, Cynober L: Approaches to studying amino acid metabolism: From quantitative assays to flux assessment using stable isotopes; in Cynober LA (ed): Metabolic and Therapeutic Aspects of Amino Acids in Clinical Nutrition, ed 2. Boca Raton, FL, CRC Press, 2004, pp 45–61.
5.
Matthews DE, Schwarz HP, Yang RD, Motil KJ, Young VR, Bier DM: Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring intracellular leucine tracer enrichment. Metabolism 1982;31:1105–1112.
6.
Schwenk WF, Beaufrère B, Haymond MW: Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol 1985;249:E646–E650.
7.
Liet JM, Piloquet H, Marchini JS, Maugère P, Bobin C, Rozé JC, Darmaun D: Leucine metabolism in preterm infants receiving parenteral nutrition with medium-chain compared with long-chain triacylglycerol emulsions. Am J Clin Nutr 1999;69:539–543.
8.
Lacey JM, Wilmore DW: Is glutamine a conditionally essential amino acid? Nutr Rev 1990;48:297–309.
9.
Des Robert C, Le Bacquer O, Piloquet H, Rozé JC, Darmaun D: Acute effects of intravenous glutamine supplementation on protein metabolism in very low birth weight infants: a stable isotope study. Pediatr Res 2002;51:87–93.
10.
Mauras N, Haymond MW, Darmaun D, Vieira NE, Abrams SA, Yergey AL: Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone. J Clin Invest 1994;93:1014–1019.
11.
Mauras N: Estrogens do not affect whole-body protein metabolism in the prepubertal female. J Clin Endocrinol Metab 1995;80:2842–2845.
12.
Mauras N, Beaufrère B: Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect. J Clin Endocrinol Metab 1995;80:869–874.
13.
Mauras N, O’Brien KO, Welch S, Rini A, Helgeson K, Vieira NE, Yergey AL: Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 2000;85:1686–1694.
14.
Darmaun D, Hayes V, Schaeffer D, Welch S, Mauras N: Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis. J Clin Endocrinol Metab 2004;89:1146–1152.
15.
Balagopal P, Ljungqvist O, Nair KS: Skeletal muscle myosin heavy-chain synthesis rate in healthy human subjects. Am J Physiol 1997;272:E45–E50.
16.
Coeffier M, Claeyssens S, Hecketsweiler B, Lavoinne A, Ducrotte P, Dechelotte P: Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. Am J Physiol Endocrinol Metab 2003;285:G266–G273.
17.
Balagopal P, Sweeten S, Mauras N: Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol 2002;282:E899–E904.
18.
Darmaun D, Roig JC, Auestad N, Sager BK, Neu J: Glutamine metabolism in very low birth weight infants. Pediatr Res 1997;41:391–396.
19.
Darmaun D, Welch S, Haymond MW: Splanchnic glutamine metabolism during prednisone-induced protein wasting in humans. Gastroenterology 1999;116:A545.
20.
Wu G, Fang YZ, Yang S, Lupton JR, Turner ND: Glutathione metabolism and its implications for health. J Nutr 2004;134:489–492.
21.
Reid M, Badaloo A, Forrester T, Morlese JF, Frazer M, Heird WC, Jahoor F: In vivo rates of erythrocyte glutathione synthesis in children with severe protein-energy malnutrition. Am J Physiol 2000;278:E405–E412.
22.
Lyons J, Rauh-Pfeiffer A, Yu YM, Lu XM, Zurakowski D, Tompkins RG, Ajami AM, Young VR, Castillo L: Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet. Proc Natl Acad Sci USA 2000;97:5071–5076.
23.
Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, Zurakowski D, Curley M, Collier S, Duggan C, Nurko S, Thompson J, Ajami A, Borgonha S, Young VR, Castillo L: Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med 2001;29:870–877.
24.
Humbert B, Nguyen P, Obled C, Bobin C, Vaslin A, Sweeten S, Darmaun D: Use of L-[(15)N] glutamic acid and homoglutathione to determine both glutathione synthesis and concentration by gas chromatography-mass spectrometry (GCMS). J Mass Spectrom 2001;36:726–735.
25.
Darmaun D, Smith SD, Sweeten S, Sager BK, Welch S, Mauras N:Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 2005;54:190–196.
26.
Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–820.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.